Page last updated: 2024-08-24

pyrrolidine dithiocarbamate and Nasopharyngeal Carcinoma

pyrrolidine dithiocarbamate has been researched along with Nasopharyngeal Carcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Feng, Y; Liu, J; Tang, Q; Xu, M; Zhu, M1

Other Studies

1 other study(ies) available for pyrrolidine dithiocarbamate and Nasopharyngeal Carcinoma

ArticleYear
The multidrug resistance can be reversed for the decrease of P-gp and LRP by inhibiting PI3K/Akt/NF-κB signal pathway in nasopharynx carcinoma.
    Bioscience reports, 2020, 05-29, Volume: 40, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrrolidines; Signal Transduction; Thiocarbamates; Transcription Factor RelA; Vault Ribonucleoprotein Particles

2020